Miao‐Zhen Qiu

机构：Sun Yat-sen University, Cancer Hospital of Chinese Academy of Medical Sciences, Sun Yat-sen University Cancer Center · ORCID：0000-0002-4774-6235

发表论文 215 篇 · 总被引 8343 次 · h-index 47

代表论文

• Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial (2024 · BMJ · 被引 265)
• Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors (2025 · Cancer Cell · 被引 32)
• YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity (2024 · Nature Communications · 被引 27)
• The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial (2025 · Nature Medicine · 被引 21)
• Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer (2024 · Signal Transduction and Targeted Therapy · 被引 20)
• Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma (2024 · Cancer Immunology Immunotherapy · 被引 17)